High- Versus Low-Dose ACE Inhibitor Therapy in Chronic Heart Failure

2004 ◽  
Vol 38 (5) ◽  
pp. 831-838 ◽  
Author(s):  
David S Roffman
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Low Dose ◽  
Ace Inhibitor ◽  
Inhibitor Therapy

ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: Hemodynamic and neurohormonal effects

2001 ◽  
Vol 141 (5) ◽  
pp. 800-807 ◽  
Author(s):  
David R. Murdoch ◽  
Theresa A. McDonagh ◽  
Rosemary Farmer ◽  
James J. Morton ◽  
John J.V. McMurray ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Receptor Antagonist ◽  
Ace Inhibitor ◽  
At1 Receptor ◽  
Inhibitor Therapy ◽  
Heart Failure Trial

Chronic heart failure patients with high collagen type I degradation marker levels benefit more with ACE-inhibitor therapy

2010 ◽  
Vol 628 (1-3) ◽  
pp. 164-170 ◽  
Author(s):  
Sofia V. Chatzikyriakou ◽  
Dimitrios N. Tziakas ◽  
Georgios K. Chalikias ◽  
Dimitrios Stakos ◽  
Adina Thomaidi ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Ace Inhibitor ◽  
Collagen Type ◽  
Collagen Type I ◽  
Inhibitor Therapy ◽  
Type I ◽  
Heart Failure Patients

Safety and efficacy of high dose ACE-inhibitor therapy in patients with chronic heart failure

1998 ◽  
Vol 4 (3) ◽  
pp. 39
Author(s):  
Casey M. Lawler ◽  
Gregory A. Ewald ◽  
Edward M. Geltman ◽  
Joseph G. Rogers
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Ace Inhibitor ◽  
Inhibitor Therapy ◽  
High Dose ◽  
Safety And Efficacy
Sign in / Sign up

Export Citation Format

Share Document